Favorite  |  Set Home
Products > Others > > TH302
Product name : TH302
Item : CR1937
Price : 100mg, $845; 200mg, $1285
contact : Send inquiry to: info@acesobio.com
Additional Information :  We offer significant discount for bulky quantity order,Please ask price and availability of other quantities
CAS : 918633-87-1
 Enlarge Image                   Back
←[Previous Product]              [Next Product]→


Details:
 

Chemical Information

M.Wt 449.04 Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Formula C9H16Br2N5O4P
CAS No 918633-87-1
Solubility

5 mg dissovled in 0.0125mL DMSO, then diluted to 1 mL with 5% NaCl solution.



Biological Activity of TH-302

 

TH-302 is selective hypoxia-activated prodrug targeting hypoxic regions of solid tumors with IC50 of 19 nM, demonstrates 270-fold enhanced cytotoxicity under hypoxia versus their potency under aerobic conditions, stable to cytochrome P450 metabolism.
IC50 value:
Target:
TH-302 is a newly developed antineoplastic drug which represents a potential new class of tumor selective hypoxia-activated prodrugs (HAPs).

 

Clinical Information of TH-302

MORE

[1]. Inhibition of Both Thioredoxin Reductase and Glutathione Reductase may Contribute to the Anticancer Mechanism of TH-302 Full Text By Li, Shengrong; Zhang, Jinsong; Li, Jun; Chen, Dongming; Matteucci, Mark; Curd, John; Duan, Jian-Xin From Biological Trace Element Research (2010), 136(3), 294-301.

[2]. Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of TH-302, a Hypoxia-Activated Prodrug, in Patients with Advanced Solid Malignancies Full Text By Weiss, Glen J.; Infante, Jeffrey R.; Chiorean

[3]. Liu Q, et al. TH-302, a hypoxia-activated prodrug with broad in vivo preclinical combination therapy efficacy: optimization of dosing regimens and schedules. Cancer Chemother Pharmacol. 2012 Jun;69(6):1487-98.

[4]. Jung D, et al. Metabolism and excretion of TH-302 in dogs. Xenobiotica. 2012 Jul;42(7):687-700.

[5]. Sun JD, et al. Selective tumor hypoxia targeting by hypoxia-activated prodrug TH-302 inhibits tumor growth in preclinical models of cancer. Clin Cancer Res. 2012 Feb 1;18(3):758-70.


Related Products :
LY 2886721
LY 2886721
Price: 10mg, $275; 50mg, $845; 100mg, $1295; 200mg, $2295
CAY10650
CAY10650
Price: 50mg, $1045;100mg, $1785
Mdivi 1
Mdivi 1
Price: 500mg, $745; 1g, $1285
PTC-209
PTC-209
Price: 200mg, $945; 500mg, $1485
ABT333
ABT333
Price: 200mg, $945; 500mg, $1485
OTSSP167
OTSSP167
Price: 100mg, $1145; 200mg, $1885
ATB 346
ATB 346
Price: 100mg, $745; 200mg, $1185
INCB024360
INCB024360
Price: 200mg, $845; 500mg, $1485